GH Research GHRS
NASDAQ GHRS
$28.01 +0.09 (+0.32%)
As of: Sep 4, 2026 · 2:31 PM EDT

GH Research (GHRS) Interest Income - Net (2021 - 2026)

GH Research (GHRS) posted quarterly Interest Income - Net of $3.6 million for Q4 2025, up 269.94% year-over-year from $962851.7 in Q4 2024, and down 75.49% quarter-over-quarter from $14.5 million in Q3 2025.

Analysis

GH Research (GHRS) Interest Income - Net (2021 - 2026) Analysis & Trends

GH Research's Interest Income - Net history runs 4 years deep, the most recent figure standing at $3.6 million for Q4 2025.

  • In Q4 2025, Interest Income - Net rose 269.94% year-over-year to $3.6 million; the TTM figure through Dec 2025 stood at $11.9 million (up 223.09% YoY), while the FY2025 annual figure was $12.7 million, up 238.79% from the prior year.
  • Interest Income - Net for Q4 2025 stood at $3.6 million, down from $14.5 million in the prior quarter.
  • The five-year high for Interest Income - Net was $14.5 million in Q3 2025, with the low at -$3.2 million in Q2 2025.
  • The 4-year median for Interest Income - Net is -$2.4 million (2024), against an average of -$600384.6.
  • The sharpest annual moves came in 2023 and 2025: Interest Income - Net tumbled 156.14% in 2023, then jumped 717.29% in 2025.
  • GH Research's Interest Income - Net stood at -$1.2 million in 2022, then sank by 156.14% to -$3.0 million in 2023, then surged by 31.12% to -$2.1 million in 2024, then soared by 269.94% to $3.6 million in 2025.
  • Business Quant data shows GHRS's Interest Income - Net at $3.6 million in Q4 2025, $14.5 million in Q3 2025, and -$3.2 million in Q2 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Interest Income - Net (Qtr)
1 Vertex Pharmaceuticals 138.77 Bn 130.92 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.51 Bn 77.52 Bn 3.93 Bn -
3 Argenx Se 63.51 Bn 58.32 Bn 1.37 Bn -
4 Moderna 58.20 Bn 53.06 Bn 52.00 Mn -
5 Revolution Medicines 44.04 Bn 44.04 Bn - -
6 BeOne Medicines 39.99 Bn 34.89 Bn 1.53 Bn -
7 Alnylam Pharmaceuticals 35.45 Bn 32.14 Bn 992.69 Mn -
8 Royalty Pharma 28.40 Bn 27.56 Bn - -
9 Insmed 27.44 Bn 26.28 Bn 358.27 Mn -
10 GH Research 1.71 Bn 1.35 Bn - 3.20 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 3.20 Mn
Mar 31, 2026 3.28 Mn
Dec 31, 2025 3.47 Mn
Sep 30, 2025 14.53 Mn
Jun 30, 2025 -2.90 Mn
Mar 31, 2025 -2.58 Mn
Dec 31, 2024 -1.93 Mn
Sep 30, 2024 -2.35 Mn
Jun 30, 2024 -2.38 Mn
Mar 31, 2024 -2.49 Mn
Dec 31, 2023 -2.74 Mn
Sep 30, 2023 -2.25 Mn
Jun 30, 2023 -1.94 Mn
Mar 31, 2023 -1.32 Mn
Dec 31, 2022 -1.29 Mn
Sep 30, 2021 -3,000.00